Showing results (551-560 of 703) with videos related to

Sort By:
Pageof 71
American Journal of Preventive Cardiology|July 30, 2021
Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiationDiana N Vikulova, Ilia S Skorniakov, Brendon Bitoiu, et al.
American Journal of Preventive Cardiology|July 30, 2021
Prevalence, treatment, and control of severe hyperlipidemiaMatthew E Gold, Michael G Nanna, Shannon M Doerfler, et al.
American Journal of Preventive Cardiology|July 30, 2021
Age-specific differences in patient reported outcomes among adults with atherosclerotic cardiovascular disease: Medical expenditure panel survey 2006-2015Victor Okunrintemi, Eve-Marie A Benson, Ouassim Derbal, et al.
American Journal of Preventive Cardiology|July 30, 2021
Estimated ASCVD risk according to statin use in US adults with borderline triglycerides: Results from National Health and Nutrition Examination Survey (NHANES) 2007-2014Wenjun Fan, Sephy Philip, Peter P Toth, et al.
American Journal of Preventive Cardiology|July 30, 2021
C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOVAdam J Nelson, Rishi Puri, Danielle M Brennan, et al.
American Journal of Preventive Cardiology|July 30, 2021
The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal studyEhimen C Aneni, Marcio Sommer Bittencourt, Catherine Teng, et al.
American Journal of Preventive Cardiology|July 30, 2021
Physical activity and sedentary behaviour in secondary prevention of coronary artery disease: A reviewVille Vasankari, Jari Halonen, Tommi Vasankari, et al.
American Journal of Preventive Cardiology|July 30, 2021
Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular diseaseTanushree Agrawal, Isaac Acquah, Amit K Dey, et al.
American Journal of Preventive Cardiology|July 30, 2021
Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United StatesSeth J Baum, Pallavi B Rane, Sasikiran Nunna, et al.
American Journal of Preventive Cardiology|July 28, 2021
Effect of government-issued state of emergency and reopening orders on cardiovascular hospitalizations during the COVID-19 pandemicSameer Arora, Michael J Hendrickson, Anthony J Mazzella, et al.
Pageof 71